IP Roundup

Premium

Agilent Technologies has received US Patent No. 7,534,561, “Nucleic acid array in situ fabrication methods and arrays produced using the same.” The patent claims methods and devices for producing nucleic acid arrays using in situ nucleic acid array synthesis protocols. According to the patent’s abstract, control probes are produced in columns on the arrays, and the probes are selected according to a particular protocol. An ‘all-bases-all-layers’ probe set is also produced in at least one column on the arrays.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.